Patients Suffering Both Stevens-Johnson Syndrome and Liver Damage Face Higher Death Risk: Study

|

The findings of a new study shows that when medications cause both a Stevens-Johnson syndrome skin reaction and liver damage, patients have lowered chances of survival. 

In a study published recently in the medical journal Hepatology, researchers from Bangalore, India found that more than a third of patients died when a drug reaction caused them to suffer both drug-induced liver injury (DILI) and either Stevens-Johnson syndrome (SJS) or the more dangerous version of SJS, toxic epidermal necrosis (TEN).

Stevens-Johnson Syndrome is a serious reaction that has been linked to a number of different medications, which involves the burning of the skin from the inside out, producing blisters, severe rash and often causing the skin to separate from the body. It also often results in vision loss or blindness.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

When the skin lesions affect more than 30% of the body, the condition is typically referred to as toxic epidermal necrolysis (TEN). Treatment in a hospital Intensive Care Unit (ICU) or Burn Unit is often required, and the conditions can be fatal in many cases.

The researchers collected data on 36 cases of Stevens-Johnson Syndrome or toxic epidermal necrosis among patients at a single clinical center in India from 1997 to 2015. Most of the cases were linked to what are considered “high risk” drugs, such as antiepileptic agents, sulfonamides, and antiretroviral drugs.

The study found that 36% of patients who suffered both liver problems and skin reactions died as a result. Those who suffered jaundice as a result of the liver problems had a 45.5% mortality rate. However, children and those with HIV suffered significantly lower death rates; 11% and 12.5%, respectively.

“DILI associated with SJS/TEN is rare and associated with a high death rate, particularly in those with jaundice; however, children and human immunodeficiency virus-infected individuals have a favorable outcome,” the researchers noted. “[A] small group of drugs contributed to a disproportioate number of cases, and causality….was highly probable in all cases.”

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Nitrous oxide injury lawsuits are emerging as medical evidence links recreational use of the gas to nerve damage that can cause numbness, balance problems and difficulty walking, often without adequate side effect warnings.
A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration.
A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March.